Lumos Diagnostics Market Risk Adjusted Performance
| LDXHF Stock | | | USD 0.16 -0.05 -23.81% |
The Market Risk Adjusted Performance signal for Lumos Diagnostics Holdings reflects patterns observed in trading data. Availability can differ across markets, exchanges, and instruments. Lumos Diagnostics has a market cap of 14.54 M, operating margin of -2.31%, current ratio of 1.05.
Correlation Analysis adds portfolio-level perspective. Including Lumos Diagnostics Holdings in a portfolio enables allocation and risk analysis. Rebalancing tools flag when weights drift from target allocations. Broader economic conditions can influence Lumos Diagnostics Holdings's company valuation — related indicators include
signals in rate.
Lumos Diagnostics Holdings has current Market Risk Adjusted Performance of
-0.02.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.02 | |
| ER[a] | = | Expected return on investing in Lumos Diagnostics |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Lumos Diagnostics Holdings is rated
below average in market risk adjusted performance across its competitive set. It is currently under evaluation in maximum drawdown across its competitive set .
Other Technical Indicators